Keyword Analysis & Research: apixaban vte nejm
Keyword Research: People who searched apixaban vte nejm also searched
Search Results related to apixaban vte nejm on Search Engine
-
ELIQUIS® (apixaban) HCP | See Boxed Warnings
https://www.bing.com/aclk?ld=e8yXegyLjARLOm8-TvV0Br9TVUCUw7_G84P--yu4LIrG-Vc1ATtxwJcHMbXSPGJx5lt9pqnq84e_inydjmPpp5VikofzYxD_eGF-n6If6VzMOe9ufDeT0SBfSQVYh_Xw1WfPLa_Yv7XPZskzsMlvAIMzKqZgOHgfrAEEw4DswYdXCRidenbcMcAyNuAfUZEfX_0SyTMQ&u=aHR0cHMlM2ElMmYlMmZ3d3cuZWxpcXVpcy5jb20lMmZlbGlxdWlzJTJmaGNwJTNmY2lkJTNkc2VtXzIzNDk2NzUlMjZvdmwlM2Rpc2klMjZ1dG1fc291cmNlJTNkTUlDUk9TT0ZUJTI2dXRtX21lZGl1bSUzZHBhaWRzZWFyY2glMjZ1dG1fY2FtcGFpZ24lM2Q3MTcwMDAwMDExMzA2NjgwOSUyNnV0bV9jb250ZW50JTNkNDM3MDAwNzc0Mjg4ODg0NzQlMjZ1dG1fdGVybSUzZGFwaXhhYmFuJTI1MjB2dGUlMjZnY2xpZCUzZDE5MjA2YzdhODBiZjFiMTM5YTdjMGE1M2Q3NTZjZTFjJTI2Z2Nsc3JjJTNkM3AuZHMlMjY&rlid=19206c7a80bf1b139a7c0a53d756ce1c
DA: 57 PA: 56 MOZ Rank: 80
-
Explore further
https://www.nejm.org/doi/full/10.1056/NEJMoa1915103
WebAug 29, 2013 · Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous thromboembolism.In this … Author: Giancarlo Agnelli, Harry R. Buller, Alexander Cohen, Madelyn Curto, Alexander S. Gallus, Margot John... Publish Year: 2013
Author: Giancarlo Agnelli, Harry R. Buller, Alexander Cohen, Madelyn Curto, Alexander S. Gallus, Margot John...
Publish Year: 2013
DA: 54 PA: 59 MOZ Rank: 32
-
Apixaban for Extended Treatment of Venous …
https://www.nejm.org/doi/full/10.1056/NEJMoa1207541
WebFeb 21, 2013 · Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the … Author: Giancarlo Agnelli, Harry R. Buller, Alexander Cohen, Madelyn Curto, Alexander S. Gallus, Margot John... Publish Year: 2013
Author: Giancarlo Agnelli, Harry R. Buller, Alexander Cohen, Madelyn Curto, Alexander S. Gallus, Margot John...
Publish Year: 2013
DA: 81 PA: 83 MOZ Rank: 36
-
Apixaban for the Treatment of Venous …
https://www.nejm.org/doi/full/10.1056/NEJMoa1915103
WebMar 29, 2020 · DOI: 10.1056/NEJMoa1915103. VOL. 382 NO. 17. Abstract. Background. Recent guidelines recommend consideration of the use of … Author: Giancarlo Agnelli, Cecilia Becattini, Guy Meyer, Andres Muñoz, Menno V Huisman, Jean M Connors, Alex... Publish Year: 2020
Author: Giancarlo Agnelli, Cecilia Becattini, Guy Meyer, Andres Muñoz, Menno V Huisman, Jean M Connors, Alex...
Publish Year: 2020
DA: 99 PA: 43 MOZ Rank: 31
-
Apixaban to Prevent Venous Thromboembolism in Patients with …
https://www.nejm.org/doi/full/10.1056/NEJMoa1814468
WebDec 4, 2018 · In conclusion, apixaban at a dose of 2.5 mg twice daily resulted in a significantly lower risk of venous thromboembolism than did placebo among ambulatory … Author: Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, Vicky Tagalakis, Sudeep Shivakumar, Ariah Schattn... Publish Year: 2019
Author: Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, Vicky Tagalakis, Sudeep Shivakumar, Ariah Schattn...
Publish Year: 2019
DA: 31 PA: 65 MOZ Rank: 31
-
Enoxaparin versus Placebo to Prevent Symptomatic Venous …
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200332
WebJun 27, 2023 · Conclusions. This trial of thromboprophylaxis in medically ill, hospitalized older adults did not demonstrate that enoxaparin reduced the risk of symptomatic VTE …
DA: 84 PA: 52 MOZ Rank: 70
-
Apixaban or Warfarin in Patients with an On-X
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300067
WebMay 6, 2023 · Patients with an On-X aortic valve implanted at least 3 months before enrollment were randomly assigned to receive apixaban 5 mg twice daily or warfarin (target international normalized ratio 2.0...
DA: 29 PA: 69 MOZ Rank: 93
-
Apixaban for extended treatment of venous thromboembolism
https://pubmed.ncbi.nlm.nih.gov/23216615/
WebFeb 21, 2013 · Conclusions: Extended anticoagulation with apixaban at either a treatment dose (5 mg) or a thromboprophylactic dose (2.5 mg) reduced the risk of recurrent venous …
DA: 4 PA: 74 MOZ Rank: 35
-
Apixaban for VTE in Patients with End-Stage Renal Disease
https://www.jwatch.org/na55434/2022/11/03/apixaban-vte-patients-with-end-stage-renal-disease
WebNov 3, 2022 · Apixaban for VTE in Patients with End-Stage Renal Disease. Daniel D. Dressler, MD, MSc, MHM, FACP, reviewing Ellenbogen MI et al. J Hosp Med 2022 Oct. …
DA: 40 PA: 19 MOZ Rank: 25
-
Apixaban for the prophylaxis and treatment of deep vein …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556259/
WebAug 26, 2015 · Currently, apixaban is US FDA-approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the prophylaxis of …
DA: 96 PA: 60 MOZ Rank: 29
-
Apixaban to Treat Venous Thromboembolism in Cancer | NEJM
https://www.nejm.org/do/10.1056/NEJMdo005717/full/
WebMar 29, 2020 · Apixaban to Treat Venous Thromboembolism in Cancer | New England Journal of Medicine. DOI: 10.1056/NEJMdo005717. Venous thromboembolism is a …
DA: 27 PA: 55 MOZ Rank: 23